Skip to main content

Table 3 Factors potentially impacting IFS detection of human brucellosis

From: Detection of Brucellae in peripheral blood mononuclear cells for monitoring therapeutic efficacy of brucellosis infection

 

IFS (Nb/%)

Total

Ρ value

+

Gender*

Male

72 (63.2%)

42 (36.8%)

114

0.01

Female

34 (85%)

6 (15%)

40

Status

Acute

48 (70.6%)

20 (29.4%)

68

0.676

Chronic

58 (67.4%)

28 (32.6%)

86

Treatment

Treated

90 (68.7%)

41 (31.3%)

131

0.934

Untreated

16 (69.9%)

7 (30.4%)

23

Therapy regimen

Routine

31 (79.5%)

8 (20.5%)

39

0.088

Addition

44 (63.8%)

25 (36.2%)

69

Mean age

43.4 ± 13.5

43.9 (68.8%)

42.2 (31.2%)

154

0.472

  1. *P value of less than 0.05 was considered significant
  2. #Routine therapy regimen indicated the standard antibiotic treatment; Additional therapy regimen indicated the standard antibiotic treatment additionally receiving immune enhancing drugs
  3. ΔTherapy regimen situation of 23 treated brucellosis patients was missing